MON­TRE­AL Af­ter No­vo Nordisk closed its cell ther­a­py unit, Cel­lu­lar In­tel­li­gence con­tract­ed neu­rol­o­gist and drug de­vel­op­er Nuno Men­donça to con­duct due dili­gence on the Dan­ish